Ascendis Pharma announces formation of VISEN Pharmaceuticals
biospectrumasia
November 14, 2018
The new company aims to develop, manufacture and commercialize the company’s endocrinology rare disease therapies in Greater China, which includes mainland China, Hong Kong, S.A.R., China, Macau, S.A.R., China and Taiwan, China